Next-Gen Immuno-Oncology Conference | Innovative Preclinical Models for Investigating Tumor-Immune Interactions

Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Boston, USA would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/register

Key highlights:-

• Updates in development of ADC's and Bispecific Ab's
• Immune Checkpoint Inhibitors and Combinations
• Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
• Biomarkers and Personalized Medicine in IO
• CAR-T Cell therapy, TCR Based-Cell Therapy
• Tumor microenvironment and Oncolytic Viruses

Who Should Attend:-

CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group Leaders, Professors, Assistant Professors, Research fellows, PhDs working on

• Monoclonal and Bispecific Antibodies
• Cell Therapy
• Immune Checkpoint Inhibitors

Become a Speaker @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/speaker-enquiry

CONFERENCE AGENDA-
Day 1-
• Registration

• Opening Remarks from the Chairperson

• Keynote Presentation (Reserved for Platinum Sponsor)

• ADC drug and its applications
……more

This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy.

Become a Sponsor @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/become-sponsor

ADDRESS:
Magarpatta City, Hadapsar, Pune, India - 411013

About Us:-
MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors.

This release was published on openPR.